About SSI Strategy
SSI Strategy is a company based in Parsippany Troy Hills (United States) founded in 2010 was acquired by Clinigen in September 2025.. SSI Strategy has completed 3 acquisitions, including Fiore Healthcare Advisors, NDA Group and Scientific Advantage. SSI Strategy offers products and services including Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance. SSI Strategy operates in a competitive market with competitors including Fusion Antibodies, Health Decisions, August Research, Phastar and ProductLife Group, among others.
- Headquarter Parsippany Troy Hills, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ssi Strategy Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Clinigen
& 2 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Fiore Healthcare Advisors
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SSI Strategy
SSI Strategy offers a comprehensive portfolio of products and services, including Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Ensures scientific integrity and stakeholder engagement
Innovates therapies through patient-centric approaches
Provides leadership for trial execution and excellence
Offers strategies for successful drug approvals
Accelerates success via strategic oversight
Unlock access to complete
Funding Insights of SSI Strategy
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Debt – Conventional - SSI Strategy | Valuation |
investors |
|
| Dec, 2020 | Amount | Private Equity Round - SSI Strategy | Valuation | Amulet Capital Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SSI Strategy
SSI Strategy has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Clinigen, Amulet Capital and HGGC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Amulet Capital is focused on healthcare private equity investments.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on middle market investments.
|
Founded Year | Domain | Location | |
|
Specialty medicines are supplied via clinical trials and access programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SSI Strategy
SSI Strategy has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Fiore Healthcare Advisors, NDA Group and Scientific Advantage. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of data safety review, auditing, and other consulting services
|
2014 | ||||
|
Medical affairs solutions including training and compliance services are offered.
|
2002 | ||||
|
Regulatory, pharmacovigilance and quality assurance services
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SSI Strategy
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ssi Strategy Comparisons
Competitors of SSI Strategy
SSI Strategy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fusion Antibodies, Health Decisions, August Research, Phastar and ProductLife Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| domain | founded_year | HQ Location |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| domain | founded_year | HQ Location |
Clinical trial services are offered in Central and Eastern Europe.
|
|
| domain | founded_year | HQ Location |
Statistical consulting and data management for clinical trials are offered.
|
|
| domain | founded_year | HQ Location |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ssi Strategy
Frequently Asked Questions about SSI Strategy
When was SSI Strategy founded?
SSI Strategy was founded in 2010 and raised its 1st funding round 10 years after it was founded.
Where is SSI Strategy located?
SSI Strategy is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.
What does SSI Strategy do?
SSI Strategy was founded in 2010 and is based in Parsippany Troy Hills, United States. Services in medical affairs, pharmacovigilance, and clinical development are provided to emerging, mid-size, and global pharmaceutical and biotech companies. Offerings include global medical affairs transformation, post-merger integration, launch preparation, pharmacovigilance system enhancements, medical planning, tactic prioritization, and emerging markets support. Scientific Advantage was acquired in October 2016 to broaden medical affairs capabilities.
Who are the top competitors of SSI Strategy?
SSI Strategy's top competitors include Fusion Antibodies, ProductLife Group and Health Decisions.
What products or services does SSI Strategy offer?
SSI Strategy offers Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance.
How many acquisitions has SSI Strategy made?
SSI Strategy has made 3 acquisitions, including Fiore Healthcare Advisors, NDA Group, and Scientific Advantage.
Who are SSI Strategy's investors?
SSI Strategy has 3 investors. Key investors include Clinigen, Amulet Capital, and HGGC.